Phase II Study of Bevacizumab, Capecitabine and Oxaliplatin in Colon Cancer

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Tae Won Kim, Asan Medical Center
ClinicalTrials.gov Identifier:
NCT00378066
First received: September 18, 2006
Last updated: January 21, 2013
Last verified: January 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2008
  Primary Completion Date: August 2006 (Final data collection date for primary outcome measure)